An MCED blood test increased screenable cancer detection more than 7-fold when added to the US Preventive Services Task Force (USPSTF) A/B recommended screening.
Fruquintinib plus sintilimab showed superior clinical benefits over investigator’s choice of axilitinib or everolimus, with a tolerable safety profile, said Zhenhua Liu, MD.
Research presented at ESMO Congress 2025 demonstrates that adolescents and young adults are aware of skin cancer, but still do not consistently practice preventive behaviors.
Emotional shock, cognitive overload, and the inherent complexity of AML present challenges for patients with AML at the time of diagnosis.
Adding osimertinib to platinum-based chemotherapy may improve outcomes in patients with EGFR-mutant, advanced NSCLC who had disease progression on first-line osimertinib.
One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.
The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.
Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a significantly higher overall risk of developing cancer, according to a systematic review and meta-analysis ...
Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu as a second-line therapy for HER2-positive metastatic breast ...
Researchers conducted a systematic review to assess the effect of certain cancer treatments on pregnancy and neonatal outcomes.
Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.